• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CARDIOVASCULAR SYSTEMS, INC. STEALTH ORBITAL ATHERECTOMY SYSTEM; PERIPHERAL ATHERECTOMY DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CARDIOVASCULAR SYSTEMS, INC. STEALTH ORBITAL ATHERECTOMY SYSTEM; PERIPHERAL ATHERECTOMY DEVICE Back to Search Results
Model Number DBE-200
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Vascular System (Circulation), Impaired (2572)
Event Date 07/23/2020
Event Type  Injury  
Manufacturer Narrative
The oad was received for analysis.No visible damage was observed.A guide wire was passed through the oad with no resistance.When tested, the oad functioned as intended.At the conclusion of the device analysis, the reported event of slow flow was unable to be confirmed.The device history record for this oad lot number has been reviewed.No issues or discrepancies were noted during this review that would have contributed to the reported event.The device met material, assembly, and quality control requirements.Csi id# (b)(4).
 
Event Description
A stealth peripheral orbital atherectomy device (oad) was selected for treatment of a lesion from the superficial femoral artery to the popliteal artery.The lesion was initially wired with a non-csi guide wire and an exchange was performed for a viperwire guide wire.The lesion was divided into five (5) segments, and each segment was treated with one treatment on low, two treatments on medium, and two treatments on high speed.The treatments were all 30 seconds, and vasodilators were administered twice during treatment.After treatment, slow flow was observed.Balloon angioplasty was performed.Lumen gain was observed, however, the flow was still slow.Stents were deployed in the sfa.The final angiography showed slower flow than baseline angioplasty.The possibility of dissection was ruled out.The physician does not plan to administer additional treatment for the slow flow.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STEALTH ORBITAL ATHERECTOMY SYSTEM
Type of Device
PERIPHERAL ATHERECTOMY DEVICE
Manufacturer (Section D)
CARDIOVASCULAR SYSTEMS, INC.
1225 old highway 8 nw
saint paul, mn
Manufacturer (Section G)
CARDIOVASCULAR SYSTEMS, INC.
1225 old highway 8 nw
saint paul, mn
Manufacturer Contact
sarah hicks
1225 old highway 8 nw
saint paul, mn 
MDR Report Key10434600
MDR Text Key203986488
Report Number3004742232-2020-00254
Device Sequence Number1
Product Code MCW
UDI-Device Identifier10850000491080
UDI-Public(01)10850000491080(17)220228(10)259471
Combination Product (y/n)N
Reporter Country CodeSN
PMA/PMN Number
K190634
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 08/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/28/2022
Device Model NumberDBE-200
Device Lot Number259471
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/01/2020
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/23/2020
Initial Date FDA Received08/20/2020
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/25/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age73 YR
Patient Weight67
-
-